These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6726506)

  • 1. From maintenance to abstinence in a therapeutic community: preliminary results.
    Sorensen JL; Acampora AP; Deitch DA
    J Psychoactive Drugs; 1984; 16(1):73-7. PubMed ID: 6726506
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
    Greenberg B; Hall DH; Sorensen JL
    J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate maintenance and abstinence--attitudes, treatment modalities and outcome.
    Ladewig D
    Drug Alcohol Depend; 1990 Apr; 25(2):245-50. PubMed ID: 2328661
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient maintenance/detoxification comparison of methadone and buprenorphine.
    Johnson RE; Fudala PJ; Collins CC; Jaffe JH
    NIDA Res Monogr; 1989; 95():384. PubMed ID: 2641003
    [No Abstract]   [Full Text] [Related]  

  • 6. Marijuana use by methadone maintenance patients.
    Saxon AJ; Calsyn DA; Blaes PA; Haver VM; Greenberg DM
    NIDA Res Monogr; 1990; 105():306-7. PubMed ID: 1876021
    [No Abstract]   [Full Text] [Related]  

  • 7. From maintenance to abstinence in a therapeutic community: follow-up outcomes.
    Sorensen JL; Acampora A; Trier M; Gold M
    J Psychoactive Drugs; 1987; 19(4):345-51. PubMed ID: 3443890
    [No Abstract]   [Full Text] [Related]  

  • 8. From maintenance to abstinence in a therapeutic community: clinical treatment methods.
    Sorensen JL; Acampora A; Iscoff D
    J Psychoactive Drugs; 1984; 16(3):229-39. PubMed ID: 6491838
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of quality of life for drug addicts in methadone maintenance treatment clinics, community and compulsory detoxification institutions in Sichuan Province].
    Xiao L; Wu Z; Wang Y; Chen J
    Wei Sheng Yan Jiu; 2009 Jan; 38(1):67-70. PubMed ID: 19267080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits.
    Fudala PJ; Johnson RE; Jaffe JH
    NIDA Res Monogr; 1990; 105():587-8. PubMed ID: 1876131
    [No Abstract]   [Full Text] [Related]  

  • 11. An alternative program for methadone maintenance dropouts: description and preliminary data.
    Goldstein MF; Deren S; Beardsley M; Richman BL
    Mt Sinai J Med; 2001 Jan; 68(1):33-40. PubMed ID: 11135504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of narcotic addicts.
    Kleber HD
    Psychiatr Med; 1985; 3(4):389-418. PubMed ID: 3916682
    [No Abstract]   [Full Text] [Related]  

  • 13. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 14. A mandatory short-term methadone-to-abstinence program in New York City.
    Winick C
    Mt Sinai J Med; 2001 Jan; 68(1):41-5. PubMed ID: 11135505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine monitoring of methadone maintenance clients: does it prevent illicit drug use?
    Havassy BE; Hall SM
    NIDA Res Monogr; 1982 Apr; 41():276-81. PubMed ID: 6811919
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal status and long-term outcomes for addicts in the DARP followup project.
    Simpson DD; Friend HJ
    NIDA Res Monogr; 1988; 86():81-98. PubMed ID: 3140037
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone maintenance outcome as a function of detoxification fear: preliminary findings.
    Milby JB; Gentile M; Sims MK; McLellan AT; Woody G; Haas N
    NIDA Res Monogr; 1990; 105():589-90. PubMed ID: 1876132
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone maintenance and male sexual dysfunction.
    Brown R; Balousek S; Mundt M; Fleming M
    J Addict Dis; 2005; 24(2):91-106. PubMed ID: 15784526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes toward methadone maintenance: implications for HIV prevention.
    Zule WA; Desmond DP
    J Psychoactive Drugs; 1998; 30(1):89-97. PubMed ID: 9565212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community pharmacist's perspective on the methadone maintenance programme. Response.
    Barron P
    N Z Bioeth J; 2001 Oct; 2(3):35-6. PubMed ID: 15587007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.